About Demeetra
Demeetra is a Healthcare company based in Lexington (United States) founded in 2018. Provider of gene-editing platform for pharmaceutical, agricultural, and industrial biotech firm. Demeetra has completed 1 acquisition, including Hera Biolabs. Its chief executive, as recorded, is Jack Crawford. Demeetra offers products and services including Cas-CLOVER, CleanCut GS CHO, Harbor-IN Transposase, and piggyBac Transposase. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is DEMEETRA AGBIO. Similar companies include Beam Therapeutics, eGenesis and Korro Bio; 3 of its 3 listed similar companies have raised funding.
Company details
Demeetra was founded in 2018 and is headquartered in Lexington, United States. Operations focus on the biotech sector, where a gene-editing platform is provided to support research in pharmaceuticals, agriculture, and industrial applications. Technologies such as CRISPRCas9 and Cas-CLOVER are utilized for DNA knockouts, knock-ins, and base-pair edits, while PiggyBac enables transposon-based insertion of genetic material for transgenics and stable cell lines.
- Headquarters Lexington, United States
- SectorsHealthcare
- Website demeetra.com
- Social LinkedIn X
- Legal Name Demeetra Agbio
- Investments & Acquisitions
Products & Services of Demeetra
Demeetra offers a comprehensive portfolio of products and services, including Cas-CLOVER, CleanCut GS CHO, Harbor-IN Transposase, and piggyBac Transposase.
Enables precise gene editing for knockouts and knock-ins in DNA.
Delivers high-productivity cells for biologics manufacturing.
Facilitates stable gene integration for bioproduction applications.
Supports efficient gene delivery in mammalian and plant cells.
People of Demeetra
1 people are tracked at Demeetra (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jack Crawford | CEO | Leadership |
Complete people profiles for Demeetra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Demeetra
Demeetra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Hera Biolabs.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of rodent models for in vitro and in vivo safety and efficacy testing services | herabiolabs.com | Lexington, United States | 2015 | Jun 2025 | •••• |
Complete acquisition details for Demeetra
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Demeetra
2 dated milestones of Demeetra across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Demeetra is founded.
- Acquisition Acquires Hera Biolabs.
Similar companies to Demeetra
Demeetra has 3 listed similar companies in our database, 3 of them funded. They include Beam Therapeutics, eGenesis and Korro Bio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beamtx.com | 2017 | Cambridge, United States | $222M | 340 | Developer of gene therapy using CRISPR base editing to treat diseases | |
| egenesisbio.com | 2015 | Cambridge, United States | $481.42M | 94 | Gene transplantation platform for humanizing pig cells is developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. |
Detailed similar companies of Demeetra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Demeetra
The website of Demeetra (demeetra.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 78.9% vs previous month
Websites whose visitors overlap most with Demeetra. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| herabiolabs.com | 100% | View details | |||
| ersgenomics.com | 96% | 3K | #5,894,072 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Demeetra (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Demeetra
Complete news archive for Demeetra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Demeetra
Demeetra was founded in 2018.
Demeetra is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Jack Crawford is the CEO of Demeetra, as recorded in our data.
Demeetra was founded in 2018 and is headquartered in Lexington, United States. Operations focus on the biotech sector, where a gene-editing platform is provided to support research in pharmaceuticals, agriculture, and industrial applications. Technologies such as CRISPRCas9 and Cas-CLOVER are utilized for DNA knockouts, knock-ins, and base-pair edits, while PiggyBac enables transposon-based insertion of genetic material for transgenics and stable cell lines.
Demeetra's top competitors include eGenesis, Korro Bio and Beam Therapeutics.
Demeetra offers Cas-CLOVER, CleanCut GS CHO, Harbor-IN Transposase, and piggyBac Transposase.
Demeetra has made 1 acquisition, including Hera Biolabs.
Demeetra operates through Demeetra Agbio.